A new funding boost was announced today for the UK’s biomedical technology sector by Business Secretary Sajid Javid at the first inter-ministerial group on business engagement. The joint £10 million Biomedical Catalyst 2016 competition between Innovate UK, the Medical Research Council and Scottish Enterprise will support development of innovative healthcare technologies that will help offer potential cures, prevent disease, manage chronic conditions or lead to earlier detection and diagnosis.

The aim of this competition is to develop innovative healthcare technologies and processes that will help provide:

  • disease prevention and proactive management of health and chronic conditions
  • earlier and better detection and diagnosis of disease leading to better patient outcomes
  • tailored treatments that either change the underlying disease or offer potential cures

This competition has 2 awards:

  • early-stage awards – to test a well-developed concept and show its effectiveness in a relevant environment
  • feasibility studies – to explore and test the commercial potential of early-stage ideas

Early-stage awards

Expected projects to range in size from total costs of £200,000 to £1.5 million. Projects should last up to 2 years. Projects must start by 1 January 2017 and end by 1 January 2019.

Feasibility studies

Total project costs of up to £200,000 are expected. Projects should last between 3 months and 1 year. Projects must start by 1 January 2017 and end by 1 January 2018.

The Biomedical Catalyst supports the best life science opportunities in the UK.

An SME must lead the project. The competition opens on 4 July 2016. You must register before noon on 7th September 2016 and must apply before noon on 14th September 2016.

Further details: https://www.gov.uk/government/publications/funding-competition-biomedical-catalyst-2016

Not right for your innovation project? View other Innovate UK funding competitions.